×
Jeśli w ciągu kilku sekund nie nastąpi przekierowanie, kliknij
tutaj
.
Wszystko
Grafika
Wiadomości
Wideo
Mapy
Zakupy
Książki
Narzędzia wyszukiwania
Szukaj w internecie
Szukaj w internecie
Tylko język polski
Najnowsze
Najnowsze
Ostatnia godzina
Ostatnie 24 godziny
Ostatni tydzień
Ostatni miesiąc
Ostatni rok
Archiwa
Według trafności
Według trafności
Według daty
Zevra adds Edsivo for vEDS to its rare disease portfolio in new...
Ehlers-Danlos News
Zevra Therapeutics is adding Edsivo (celiprolol), an experimental therapy for vascular Ehlers-Danlos syndrome (vEDS), to its clinical...
7 miesięcy temu
Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review
ScienceDirect.com
This update review addressed drug interactions precipitated by fruit juices other than grapefruit juice based on RCTs. •. Some fruit juices other than...
74 miesiące temu
Acer Therapeutics Axes 60% of Workforce after FDA Rebuff
Genetic Engineering and Biotechnology News
Acer Therapeutics has eliminated about 60% of its workforce—29 jobs—and halted pre-commercialization activities for its lead candidate...
57 miesięcy temu
Should You Make Dietary Changes When Taking Beta-Blockers?
Healthline
Beta-blockers are medications used to treat heart disease. This article presents supplements and foods to avoid when taking carvedilol and...
34 miesiące temu
FDA kicks back Acer's rare disease drug, demands new test—shares in freefall
Fierce Biotech
Acer Therapeutics' stock plummeted more than 78% premarket this morning on news that the FDA had rejected approval of its drug Edsivo...
58 miesięcy temu
Sneezing-Induced Subclavian Arterial Rupture: A Case of Vascular Ehlers-Danlos Syndrome in a Child
Cureus
Vascular Ehlers-Danlos syndrome is a fatal disease caused by a type III collagen mutation that can result in the rupture of blood vessels,...
3 miesiące temu
Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled ...
Nature
Beta-adrenergic blocking agents (abbreviated as beta-blockers) have been used for treating various cardiovascular diseases.
39 miesięcy temu
Celiprolol May Be Protective in COL3A1-positive Vascular EDS Patients
Ehlers-Danlos News
Celiprolol may have protective effects in COL3A1-positive vascular Ehlers-Danlos syndrome patients, according to results of a long-term...
38 miesięcy temu
Edsivo Gets Breakthrough Therapy Status for Vascular Ehlers-Danlos Syndrome
Medical Professionals Reference
The FDA has granted Breakthrough Therapy designation to Edsivo (celiprolol) for the treatment of patients with COL3A1-positive vEDS.
24 miesiące temu
Acer Therapeutics Readies for FDA Ruling on UCDs Drug
BioSpace
On June 5, the FDA is expected to decide the fate of Acer Therapeutics' experimental treatment for Urea Cycle Disorders (UCDs), ACER-001.
22 miesiące temu